Literature DB >> 7639060

Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation.

N K Olsen1, A W Hansen, S Nørby, A L Edal, J R Jørgensen, T Rosenberg.   

Abstract

This report describes a multiple sclerosis (MS)-like disorder in a male patient with Leber's hereditary optic neuropathy (LHON) harbouring the mitochondrial DNA 11778 base pair mutation. Given the population frequencies of MS and LHON, coincidental occurrence is unlikely. Hypothetically the mitochondrial mutation underlying LHON may contribute to presumably immunologically mediated involvement of other myelinated axons in the central nervous system in susceptible individuals, producing a disorder indistinguishable from MS. We recommend that investigation for oligoclonal bands in CSF, evoked potentials and MR brain scan in these patients be supplemented with mitochondrial DNA analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639060     DOI: 10.1111/j.1600-0404.1995.tb07016.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy.

Authors:  M Inglese; M Rovaris; S Bianchi; L La Mantia; G L Mancardi; A Ghezzi; P Montagna; F Salvi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Mimicry between mitochondrial disorder and multiple sclerosis.

Authors:  Josef Finsterer; Romana Höftberger; Claudia Stöllberger; Boris Rolinski
Journal:  Metab Brain Dis       Date:  2012-02-05       Impact factor: 3.584

3.  Mitochondrial mutation in Iranian patients with multiple sclerosis, correlation between haplogroups H, A and clinical manifestations.

Authors:  Mojdeh Ghabaee; Motahar Omranisikaroudi; Shahla Amrisaroukolaei; Alipasha Meysamie; Mohammad Ali Sahraian; Asghar Bayati; Mohammad Hossein Sanati; Mossoud Houshman; Homa Sadeghian; Khalili Vajihazaman
Journal:  Cell Mol Neurobiol       Date:  2008-11-14       Impact factor: 5.046

Review 4.  Leber hereditary optic neuropathy.

Authors:  P Yu-Wai-Man; D M Turnbull; P F Chinnery
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

5.  Analysis of the entire mitochondrial genome reveals Leber's hereditary optic neuropathy mitochondrial DNA mutations in an Arab cohort with multiple sclerosis.

Authors:  Ghada Al-Kafaji; Maram A Alharbi; Hasan Alkandari; Abdel Halim Salem; Moiz Bakhiet
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

6.  Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Authors:  William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Journal:  J Neurol Sci       Date:  2008-09-09       Impact factor: 3.181

Review 7.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Investigation on mitochondrial tRNA(Leu/Lys), NDI and ATPase 6/8 in Iranian multiple sclerosis patients.

Authors:  Solmaz Etemad Ahari; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Sadaf Kasraie; Mostafa Moin; Mohammad Ali Bahar
Journal:  Cell Mol Neurobiol       Date:  2007-07-06       Impact factor: 5.046

9.  Brain white matter changes in asymptomatic carriers of Leber's hereditary optic neuropathy.

Authors:  Miaomiao Long; Ling Wang; Qin Tian; Hao Ding; Wen Qin; Dapeng Shi; Chunshui Yu
Journal:  J Neurol       Date:  2019-03-25       Impact factor: 4.849

Review 10.  Mitochondrial DNA sequence variation and neurodegeneration.

Authors:  Michelangelo Mancuso; Massimiliano Filosto; Daniele Orsucci; Gabriele Siciliano
Journal:  Hum Genomics       Date:  2008-09       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.